annual CFF:
-$49.09M-$43.96M(-856.96%)Summary
- As of today (July 26, 2025), AUPH annual cash flow from financing activities is -$49.09 million, with the most recent change of -$43.96 million (-856.96%) on December 31, 2024.
- During the last 3 years, AUPH annual CFF has fallen by -$270.20 million (-122.20%).
- AUPH annual CFF is now -120.13% below its all-time high of $243.85 million, reached on December 31, 2019.
Performance
AUPH Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$49.34M-$26.29M(-114.08%)Summary
- As of today (July 26, 2025), AUPH quarterly cash flow from financing activities is -$49.34 million, with the most recent change of -$26.29 million (-114.08%) on March 31, 2025.
- Over the past year, AUPH quarterly CFF has dropped by -$34.29 million (-227.80%).
- AUPH quarterly CFF is now -123.98% below its all-time high of $205.72 million, reached on December 31, 2021.
Performance
AUPH quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$83.38M-$34.29M(-69.84%)Summary
- As of today (July 26, 2025), AUPH TTM cash flow from financing activities is -$83.38 million, with the most recent change of -$34.29 million (-69.84%) on March 31, 2025.
- Over the past year, AUPH TTM CFF has dropped by -$61.56 million (-282.12%).
- AUPH TTM CFF is now -121.38% below its all-time high of $390.05 million, reached on September 30, 2020.
Performance
AUPH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AUPH Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -857.0% | -227.8% | -282.1% |
| 3 y3 years | -122.2% | -10000.0% | -138.5% |
| 5 y5 years | -120.1% | -1788.5% | -138.7% |
AUPH Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -122.2% | at low | -3110.2% | at low | -138.5% | at low |
| 5 y | 5-year | -120.1% | at low | -124.0% | at low | -121.4% | at low |
| alltime | all time | -120.1% | at low | -124.0% | at low | -121.4% | at low |
AUPH Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$49.34M(+114.1%) | -$83.38M(+69.8%) |
| Dec 2024 | -$49.09M(+857.0%) | -$23.05M(+746.7%) | -$49.09M(+55.2%) |
| Sep 2024 | - | -$2.72M(-67.1%) | -$31.62M(+1.2%) |
| Jun 2024 | - | -$8.27M(-45.0%) | -$31.23M(+43.1%) |
| Mar 2024 | - | -$15.05M(+169.9%) | -$21.82M(+325.3%) |
| Dec 2023 | -$5.13M(-310.9%) | -$5.58M(+139.2%) | -$5.13M(-552.0%) |
| Sep 2023 | - | -$2.33M(-304.6%) | $1.14M(-67.3%) |
| Jun 2023 | - | $1.14M(-30.4%) | $3.47M(-5.5%) |
| Mar 2023 | - | $1.64M(+138.2%) | $3.67M(+50.7%) |
| Dec 2022 | $2.43M(-98.9%) | $688.00K(>+9900.0%) | $2.43M(-98.8%) |
| Sep 2022 | - | $0.00(-100.0%) | $207.47M(-4.2%) |
| Jun 2022 | - | $1.34M(+230.9%) | $216.55M(+0.0%) |
| Mar 2022 | - | $405.00K(-99.8%) | $216.49M(-2.1%) |
| Dec 2021 | $221.11M(+13.8%) | $205.72M(+2165.2%) | $221.11M(+1229.4%) |
| Sep 2021 | - | $9.08M(+610.1%) | $16.63M(-91.5%) |
| Jun 2021 | - | $1.28M(-74.6%) | $196.81M(+0.2%) |
| Mar 2021 | - | $5.03M(+304.9%) | $196.48M(+1.1%) |
| Dec 2020 | $194.38M(-20.3%) | $1.24M(-99.3%) | $194.38M(-50.2%) |
| Sep 2020 | - | $189.26M(>+9900.0%) | $390.05M(+80.9%) |
| Jun 2020 | - | $954.00K(-67.4%) | $215.64M(+0.2%) |
| Mar 2020 | - | $2.92M(-98.5%) | $215.13M(-11.8%) |
| Dec 2019 | $243.85M(+5975.1%) | $196.92M(+1226.0%) | $243.85M(+412.8%) |
| Sep 2019 | - | $14.85M(+3314.0%) | $47.55M(+45.4%) |
| Jun 2019 | - | $435.00K(-98.6%) | $32.71M(-8.3%) |
| Mar 2019 | - | $31.65M(+5071.7%) | $35.66M(+788.5%) |
| Dec 2018 | $4.01M(-97.7%) | $612.00K(+7550.0%) | $4.01M(+16.1%) |
| Sep 2018 | - | $8000.00(-99.8%) | $3.46M(-26.3%) |
| Jun 2018 | - | $3.39M(>+9900.0%) | $4.69M(+57.9%) |
| Mar 2018 | - | $0.00(-100.0%) | $2.97M(-98.3%) |
| Dec 2017 | $175.15M(+311.0%) | $55.00K(-95.6%) | $175.15M(-14.0%) |
| Sep 2017 | - | $1.24M(-25.7%) | $203.64M(-3.0%) |
| Jun 2017 | - | $1.67M(-99.0%) | $209.83M(-2.3%) |
| Mar 2017 | - | $172.18M(+503.3%) | $214.79M(+404.0%) |
| Dec 2016 | $42.62M(+4979.3%) | $28.54M(+283.9%) | $42.62M(+202.8%) |
| Sep 2016 | - | $7.43M(+12.0%) | $14.07M(+110.2%) |
| Jun 2016 | - | $6.64M(>+9900.0%) | $6.70M(+1324.7%) |
| Mar 2016 | - | $0.00(0.0%) | $470.00K(-44.0%) |
| Dec 2015 | $839.00K(-98.2%) | $0.00(-100.0%) | $839.00K(-39.2%) |
| Sep 2015 | - | $56.00K(-86.5%) | $1.38M(-23.4%) |
| Jun 2015 | - | $414.00K(+12.2%) | $1.80M(+26.7%) |
| Mar 2015 | - | $369.00K(-31.9%) | $1.42M(-97.0%) |
| Dec 2014 | $47.89M(+651.2%) | $542.00K(+13.6%) | $47.89M(+1.2%) |
| Sep 2014 | - | $477.00K(+1302.9%) | $47.34M(-9.6%) |
| Jun 2014 | - | $34.00K(-99.9%) | $52.39M(-1.6%) |
| Mar 2014 | - | $46.84M(<-9900.0%) | $53.22M(+734.8%) |
| Dec 2013 | $6.38M(+789.5%) | -$6000.00(-100.1%) | $6.38M(-10.6%) |
| Sep 2013 | - | $5.53M(+541.2%) | $7.13M(+347.9%) |
| Jun 2013 | - | $862.00K(<-9900.0%) | $1.59M(+121.2%) |
| Mar 2013 | - | -$8000.00(-101.1%) | $719.70K(+0.4%) |
| Dec 2012 | $716.70K(-68.6%) | $750.20K(-6404.2%) | $716.70K(-8734.9%) |
| Sep 2012 | - | -$11.90K(+12.3%) | -$8300.00(-94.7%) |
| Jun 2012 | - | -$10.60K(-3.6%) | -$157.60K(+13.7%) |
| Mar 2012 | - | -$11.00K(-143.7%) | -$138.60K(-106.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $2.28M(-50.9%) | $25.20K(-115.6%) | $2.28M(-1.8%) |
| Sep 2011 | - | -$161.20K(-2019.0%) | $2.32M(-67.0%) |
| Jun 2011 | - | $8400.00(-99.7%) | $7.05M(-0.1%) |
| Mar 2011 | - | $2.41M(+3507.3%) | $7.05M(+51.9%) |
| Dec 2010 | $4.64M(-148.3%) | $66.80K(-98.5%) | $4.64M(+6.0%) |
| Sep 2010 | - | $4.56M(>+9900.0%) | $4.38M(-568.9%) |
| Jun 2010 | - | $16.10K(>+9900.0%) | -$934.20K(+3808.8%) |
| Mar 2010 | - | $0.00(-100.0%) | -$23.90K(-99.8%) |
| Dec 2009 | -$9.61M(-193.1%) | -$196.00K(-74.0%) | -$9.61M(-12.3%) |
| Sep 2009 | - | -$754.30K(-181.4%) | -$10.96M(+1.1%) |
| Jun 2009 | - | $926.40K(-109.7%) | -$10.84M(-1121.9%) |
| Mar 2009 | - | -$9.59M(+520.7%) | $1.06M(-89.7%) |
| Dec 2008 | $10.32M(-71.4%) | -$1.54M(+142.5%) | $10.32M(-10.4%) |
| Sep 2008 | - | -$636.90K(-105.0%) | $11.52M(-18.8%) |
| Jun 2008 | - | $12.83M(-4041.6%) | $14.19M(+288.9%) |
| Mar 2008 | - | -$325.50K(-5.2%) | $3.65M(-89.9%) |
| Dec 2007 | $36.03M(-2932.0%) | -$343.40K(-117.0%) | $36.03M(-0.0%) |
| Sep 2007 | - | $2.02M(-11.7%) | $36.04M(+7.2%) |
| Jun 2007 | - | $2.29M(-92.9%) | $33.60M(+8.6%) |
| Mar 2007 | - | $32.06M(-9681.2%) | $30.94M(-2531.9%) |
| Dec 2006 | -$1.27M(-108.3%) | -$334.60K(-18.7%) | -$1.27M(+62.2%) |
| Sep 2006 | - | -$411.70K(+10.1%) | -$784.40K(-105.2%) |
| Jun 2006 | - | -$374.10K(+146.4%) | $15.10M(-2.3%) |
| Mar 2006 | - | -$151.80K(-199.1%) | $15.46M(+1.3%) |
| Dec 2005 | $15.26M(+213.7%) | $153.20K(-99.0%) | $15.26M(-4.6%) |
| Sep 2005 | - | $15.47M(<-9900.0%) | $16.00M(+252.1%) |
| Jun 2005 | - | -$12.80K(-96.3%) | $4.55M(+0.6%) |
| Mar 2005 | - | -$348.00K(-138.8%) | $4.52M(-7.1%) |
| Dec 2004 | $4.87M(-80.2%) | $896.20K(-77.6%) | $4.87M(+9.7%) |
| Sep 2004 | - | $4.01M(<-9900.0%) | $4.43M(-69.9%) |
| Jun 2004 | - | -$39.00K(+2500.0%) | $14.72M(-40.9%) |
| Mar 2004 | - | -$1500.00(-100.3%) | $24.90M(+1.1%) |
| Dec 2003 | $24.62M(+103.5%) | $465.10K(-96.7%) | $24.62M(+2.7%) |
| Sep 2003 | - | $14.30M(+41.1%) | $23.97M(+164.3%) |
| Jun 2003 | - | $10.13M(-3719.5%) | $9.07M(+6.0%) |
| Mar 2003 | - | -$280.00K(+57.0%) | $8.56M(-29.2%) |
| Dec 2002 | $12.10M(-60.2%) | -$178.30K(-70.5%) | $12.10M(-1.5%) |
| Sep 2002 | - | -$604.60K(-106.3%) | $12.27M(-61.2%) |
| Jun 2002 | - | $9.62M(+195.5%) | $31.61M(+33.0%) |
| Mar 2002 | - | $3.26M(-82.6%) | $23.76M(-5.4%) |
| Dec 2001 | $30.41M(+91.4%) | - | - |
| Aug 2001 | - | $18.73M(+956.9%) | $25.13M(+232.8%) |
| May 2001 | - | $1.77M(+154.1%) | $7.55M(-49.7%) |
| Feb 2001 | - | $697.70K(-82.2%) | $15.00M(-5.6%) |
| Nov 2000 | $15.89M(+277.4%) | $3.92M(+238.1%) | $15.89M(+5.6%) |
| Aug 2000 | - | $1.16M(-87.4%) | $15.04M(+12.9%) |
| May 2000 | - | $9.23M(+482.1%) | $13.33M(+193.8%) |
| Feb 2000 | - | $1.58M(-48.4%) | $4.54M(+7.7%) |
| Nov 1999 | $4.21M(+169.5%) | $3.07M(-650.7%) | $4.21M(+270.1%) |
| Aug 1999 | - | -$558.00K(-228.0%) | $1.14M(-32.9%) |
| May 1999 | - | $436.00K(-65.4%) | $1.70M(+34.6%) |
| Feb 1999 | - | $1.26M | $1.26M |
| Nov 1998 | $1.56M | - | - |
FAQ
- What is Aurinia Pharmaceuticals Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. annual CFF year-on-year change?
- What is Aurinia Pharmaceuticals Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. quarterly CFF year-on-year change?
- What is Aurinia Pharmaceuticals Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. TTM CFF year-on-year change?
What is Aurinia Pharmaceuticals Inc. annual cash flow from financing activities?
The current annual CFF of AUPH is -$49.09M
What is the all time high annual CFF for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high annual cash flow from financing activities is $243.85M
What is Aurinia Pharmaceuticals Inc. annual CFF year-on-year change?
Over the past year, AUPH annual cash flow from financing activities has changed by -$43.96M (-856.96%)
What is Aurinia Pharmaceuticals Inc. quarterly cash flow from financing activities?
The current quarterly CFF of AUPH is -$49.34M
What is the all time high quarterly CFF for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high quarterly cash flow from financing activities is $205.72M
What is Aurinia Pharmaceuticals Inc. quarterly CFF year-on-year change?
Over the past year, AUPH quarterly cash flow from financing activities has changed by -$34.29M (-227.80%)
What is Aurinia Pharmaceuticals Inc. TTM cash flow from financing activities?
The current TTM CFF of AUPH is -$83.38M
What is the all time high TTM CFF for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high TTM cash flow from financing activities is $390.05M
What is Aurinia Pharmaceuticals Inc. TTM CFF year-on-year change?
Over the past year, AUPH TTM cash flow from financing activities has changed by -$61.56M (-282.12%)